NCT00866918 · OUTCOME

Hematologic Remission Rate

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · Source last updated 2022-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

Proportion of patients in hematologic remission at end of consolidation, course 1 are reported.

Analysis population: Patients who were ineligible (n=6), inevaluable (n=1), or who electively withdrew during Induction (n=4) were excluded.

WBC\<10,000/MicroLiter

WBC\>=10,000/MicroLiter

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Standard Risk	63
High Risk	34

Source class 1

Values in Proportion of participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Standard Risk	1.0000	Not reported	Not reported	Not reported	Not reported
High Risk	0.8824	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

denoms

description

Proportion of patients in hematologic remission at end of consolidation, course 1 are reported.

groups

param Type

NUMBER

population Description

Patients who were ineligible (n=6), inevaluable (n=1), or who electively withdrew during Induction (n=4) were excluded.

reporting Status

POSTED

time Frame

End of consolidation, course 1: up to 5 months

title

Hematologic Remission Rate

type

SECONDARY

unit Of Measure

Proportion of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice